NDC 0409-5093 – Tazicef

Ceftazidime 2 g/1 · Injection, Powder, For Solution · Intravenous

Human Prescription Drug

Product NDC0409-5093

Product details

Brand name
Tazicef
Generic name
Ceftazidime
Labeler
Hospira, Inc.
Dosage form
Injection, Powder, For Solution
Route
Intravenous
Marketing category
ANDA · ANDA064032
Marketed since
April 5, 2006
Marketing end
September 30, 2026
Pharmacologic class
Cephalosporin Antibacterial

Active ingredients

Uses, dosage, side effects and warnings for Tazicef →

Package NDC codes (1)

Package NDCDescriptionSince
0409-5093-1110 VIAL, PATENT DELIVERY SYSTEM in 1 CARTON (0409-5093-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, PATENT DELIVERY SYSTEM (0409-5093-14)Apr 5, 2006

Other Tazicef products